COVID-19 and drugs

How is the COVID-19 pandemic affecting drug users and those who provide services to them? Has there been an impact on the drug market? Are you looking for reliable resources on the topic? Find out more on our COVID-19 and drugs hub page.

COVID-19 and drugs »

Featured publications  

EU Drug Markets Report

err 2019 cover

European Drug Report

cover

Drugs in syringes from six European cities 

 

Recent changes in Europe’s cocaine market

Medical use of cannabis and cannabinoids

m-Health applications for responding to drug use and associated harms

 
Wastewater POD's cover

Wastewater analysis and drugs — a European multi-city study

Publication thumbnail

Drugs and the darknet

Health and social responses to drug problems: a European guide

  Recent videos  

  Data visualisations  

Interactive: wastewater analysis and drugsMap showing patterns of drug use across European cities
Infographic: Number of presentations to Euro-DEN Plus centres, 2017Map eurodmn plus centres 2017
Location of Euro-DEN Plus centres - update 31 December 2019
Map: Location of sites related to amphetamine production in the EU, 2015-17Map showing the location of sites related to amphetamine production in the EU, 2015-17
Infographic: new psychoactive substances (NPS) overview — substances reported to the EU Early Warning System since 1997Infographic showing overview of NPS in Europe
Map: location of sites related to MDMA production in the EU, 2015-17Map showing the location of sites related to MDMA production in the EU, 2015-17
Infographic: EU retail drug market size minimum estimate (2017)EU drug retail market is estimated to be 30 billion Euro anually based on data from 2017
Map: location of sites related to methamphetamine production in the EU, 2015-17map showing location of sites related to methamphetamine production in the EU, 2015-17
Infographic: key impacts and consequences of drug marketsConceptual graphic showing key impacts and consequences of drug markets

  Explore emcdda.europa.eu

Spotlight